Telomir Pharmaceuticals, Inc.
8-K
March 27, 2026
Key Highlights
- Strategic acquisition of Teli Pharmaceuticals to accelerate clinical development
- Expansion of telomere-lengthening pipeline to advance FDA filings
- Projected 15% growth in combined research and development budget
Read Analysis
🤖 AI Generated